Warwick spin-out Histofy to revolutionise AI for cellular pathology.

Equipping entrepreneurs and start-ups with the tools needed to solve global challenges.

NanoSyrinx raises £6.2m to develop its synthetic biology platform for targeted intracellular engineering.

Warwick spin out company Medherant to develop world’s only testosterone patch for menopause.